Lymphocyte recovery after fingolimod discontinuation in patients with MS

OBJECTIVE: To investigate the dynamics of immune cells recovery after treatment discontinuation of fingolimod in real-life clinical practice, we analyzed the course of lymphocyte reconstitution and its potential influencing factors in patients with multiple sclerosis (MS). METHODS: We analyzed leuko...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagy, Sara, Kuhle, Jens, Derfuss, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641093/
https://www.ncbi.nlm.nih.gov/pubmed/32801166
http://dx.doi.org/10.1212/NXI.0000000000000874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641093/
https://www.ncbi.nlm.nih.gov/pubmed/32801166
http://dx.doi.org/10.1212/NXI.0000000000000874

Ejemplares similares